Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03158116 · ClinicalTrials.gov registry record · Phase 4
The Use of Inhaled Aztreonam in Children With a Tracheostomy Tube and Pseudomonas
A Phase 4 study, sponsored by UCSF Benioff Children's Hospital Oakland.
- Terminated
- Registry status
- Phase 4
- Development phase
- 5
- Enrollment target
NCT03158116: Clinical Trial Phase 4 study, sponsored by UCSF Benioff Children's Hospital Oakland.
NCT03158116 is a Phase 4 study that was terminated before completion, run by UCSF Benioff Children's Hospital Oakland. The registered enrollment target is 5 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03158116, a Phase 4 study, was terminated before completion, sponsored by UCSF Benioff Children's Hospital Oakland.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 5 participants
- Enrollment target
Study Summary
This is a prospective, case-control clinical trial using inhaled Aztreonam (AZLI) in pediatric patients with a tracheostomy tube colonized with Pseudomonas aeruginosa. The aim of the study is to see if AZLI being taken in a one month on / one month off cycle over the course of a year can decrease the need for systemic antibiotics and/or hospitalizations.
Interventions
- DRUG Inhaled Aztreonam
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2017-07-01 |
| Est. Completion | 2020-02-20 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03158116
The ClinicalTrials.gov registry entry for NCT03158116 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is UCSF Benioff Children's Hospital Oakland, which has 52 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Inhaled Aztreonam is the first listed.
NCT03158116 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03158116 about?
NCT03158116 is a clinical study titled "The Use of Inhaled Aztreonam in Children With a Tracheostomy Tube and Pseudomonas". This is a prospective, case-control clinical trial using inhaled Aztreonam (AZLI) in pediatric patients with a tracheostomy tube colonized with Pseudomonas aeruginosa. The aim of the study is to see if AZLI being taken in a one month on / one month off cycle over the course of a year can decrease th...
What is the current status of trial NCT03158116?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 5 participants. The study started on 2017-07-01. Estimated completion is 2020-02-20.
What interventions are being tested in trial NCT03158116?
The interventions under investigation include: Inhaled Aztreonam (DRUG).
Who is sponsoring clinical trial NCT03158116?
This trial is sponsored by UCSF Benioff Children's Hospital Oakland, which has 52 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.